505 related articles for article (PubMed ID: 20237129)
1. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
Comabella M; Fernández M; Martin R; Rivera-Vallvé S; Borrás E; Chiva C; Julià E; Rovira A; Cantó E; Alvarez-Cermeño JC; Villar LM; Tintoré M; Montalban X
Brain; 2010 Apr; 133(Pt 4):1082-93. PubMed ID: 20237129
[TBL] [Abstract][Full Text] [Related]
2. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis.
Modvig S; Degn M; Roed H; Sørensen TL; Larsson HB; Langkilde AR; Frederiksen JL; Sellebjerg F
Mult Scler; 2015 Dec; 21(14):1761-70. PubMed ID: 25698172
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
[TBL] [Abstract][Full Text] [Related]
5. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.
Hinsinger G; Galéotti N; Nabholz N; Urbach S; Rigau V; Demattei C; Lehmann S; Camu W; Labauge P; Castelnovo G; Brassat D; Loussouarn D; Salou M; Laplaud D; Casez O; Bockaert J; Marin P; Thouvenot E
Mult Scler; 2015 Sep; 21(10):1251-61. PubMed ID: 25698171
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis.
Møllgaard M; Degn M; Sellebjerg F; Frederiksen JL; Modvig S
Eur J Neurol; 2016 May; 23(5):898-905. PubMed ID: 26872061
[TBL] [Abstract][Full Text] [Related]
7. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
[TBL] [Abstract][Full Text] [Related]
8. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid.
Timirci-Kahraman O; Karaaslan Z; Tuzun E; Kurtuncu M; Baykal AT; Gunduz T; Tuzuner MB; Akgun E; Gurel B; Eraksoy M; Kucukali CI
Acta Neurol Belg; 2019 Mar; 119(1):101-111. PubMed ID: 29873030
[TBL] [Abstract][Full Text] [Related]
10. Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Cantó E; Tintoré M; Villar LM; Borrás E; Alvarez-Cermeño JC; Chiva C; Sabidó E; Rovira A; Montalban X; Comabella M
J Neuroinflammation; 2014 Nov; 11():181. PubMed ID: 25406498
[TBL] [Abstract][Full Text] [Related]
11. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Kuhle J; Disanto G; Dobson R; Adiutori R; Bianchi L; Topping J; Bestwick JP; Meier UC; Marta M; Dalla Costa G; Runia T; Evdoshenko E; Lazareva N; Thouvenot E; Iaffaldano P; Direnzo V; Khademi M; Piehl F; Comabella M; Sombekke M; Killestein J; Hegen H; Rauch S; D'Alfonso S; Alvarez-Cermeño JC; Kleinová P; Horáková D; Roesler R; Lauda F; Llufriu S; Avsar T; Uygunoglu U; Altintas A; Saip S; Menge T; Rajda C; Bergamaschi R; Moll N; Khalil M; Marignier R; Dujmovic I; Larsson H; Malmestrom C; Scarpini E; Fenoglio C; Wergeland S; Laroni A; Annibali V; Romano S; Martínez AD; Carra A; Salvetti M; Uccelli A; Torkildsen Ø; Myhr KM; Galimberti D; Rejdak K; Lycke J; Frederiksen JL; Drulovic J; Confavreux C; Brassat D; Enzinger C; Fuchs S; Bosca I; Pelletier J; Picard C; Colombo E; Franciotta D; Derfuss T; Lindberg R; Yaldizli Ö; Vécsei L; Kieseier BC; Hartung HP; Villoslada P; Siva A; Saiz A; Tumani H; Havrdová E; Villar LM; Leone M; Barizzone N; Deisenhammer F; Teunissen C; Montalban X; Tintoré M; Olsson T; Trojano M; Lehmann S; Castelnovo G; Lapin S; Hintzen R; Kappos L; Furlan R; Martinelli V; Comi G; Ramagopalan SV; Giovannoni G
Mult Scler; 2015 Jul; 21(8):1013-24. PubMed ID: 25680984
[TBL] [Abstract][Full Text] [Related]
12. Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
Correale J; Fiol M
Mult Scler; 2011 May; 17(5):521-31. PubMed ID: 21159721
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome.
Ferraro D; Simone AM; Bedin R; Galli V; Vitetta F; Federzoni L; D'Amico R; Merelli E; Nichelli PF; Sola P
J Neuroimmunol; 2013 Apr; 257(1-2):76-81. PubMed ID: 23434160
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid chitinase-3-like protein 1 level is not an independent predictive factor for the risk of clinical conversion in radiologically isolated syndrome.
Thouvenot E; Hinsinger G; Demattei C; Uygunoglu U; Castelnovo G; Pittion-Vouyovitch S; Okuda D; Kantarci O; Pelletier D; Lehmann S; Marin P; Siva A; Lebrun C
Mult Scler; 2019 Apr; 25(5):669-677. PubMed ID: 29564952
[TBL] [Abstract][Full Text] [Related]
15. Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis.
Borràs E; Cantó E; Choi M; Maria Villar L; Álvarez-Cermeño JC; Chiva C; Montalban X; Vitek O; Comabella M; Sabidó E
Mol Cell Proteomics; 2016 Jan; 15(1):318-28. PubMed ID: 26552840
[TBL] [Abstract][Full Text] [Related]
16. Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Tintore M; Rovira À; Río J; Otero-Romero S; Arrambide G; Tur C; Comabella M; Nos C; Arévalo MJ; Negrotto L; Galán I; Vidal-Jordana A; Castilló J; Palavra F; Simon E; Mitjana R; Auger C; Sastre-Garriga J; Montalban X
Brain; 2015 Jul; 138(Pt 7):1863-74. PubMed ID: 25902415
[TBL] [Abstract][Full Text] [Related]
17. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
18. Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.
Kolčava J; Kočica J; Hulová M; Dušek L; Horáková M; Keřkovský M; Stulík J; Dostál M; Kuhn M; Vlčková E; Bednařík J; Benešová Y
Mult Scler Relat Disord; 2020 Sep; 44():102262. PubMed ID: 32570179
[TBL] [Abstract][Full Text] [Related]
19. CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment.
Malmeström C; Axelsson M; Lycke J; Zetterberg H; Blennow K; Olsson B
J Neuroimmunol; 2014 Apr; 269(1-2):87-9. PubMed ID: 24582001
[TBL] [Abstract][Full Text] [Related]
20. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]